Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1

Status

Recruiting 3Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 33Brain Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Neoplasm Metastasis 17Lung Neoplasms 15Carcinoma, Hepatocellular 13Breast Neoplasms 10Pancreatic Neoplasms 9Melanoma 9Carcinoma, Renal Cell 9Neoplasms 6Colorectal Neoplasms 6Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Spinal Cord Neoplasms 3Small Cell Lung Carcinoma 3Prostate Cancer Metastatic 3Nasopharyngeal Carcinoma 3Kidney Neoplasms 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Sarcoma 2Radiation Injuries 2Osteosarcoma 2Oligometastatic Prostate Cancer 2Neuroma, Acoustic 2Neoplasms by Site 2Klatskin Tumor 2Head and Neck Neoplasms 2

Interventions

Oxaliplatin 10pembrolizumab 8Fluorouracil 8Leucovorin 7Paclitaxel 5Gemcitabine 5Docetaxel 5Capecitabine 5Cyclophosphamide 4Blood Specimen Collection 4zolbetuximab 3fludarabine 3darolutamide 3cemiplimab 3Trastuzumab 3Taxes 3Ramucirumab 3Radiotherapy 3Radiosurgery 3Irinotecan 3trastuzumab deruxtecan 2enzalutamide 2durvalumab 2Standard of Care 2Nivolumab 2Folfox protocol 2Dexamethasone 2Cisplatin 2130-nm albumin-bound paclitaxel 2tucatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma × Radiosurgery × Clear all
NCT07426055 2026-03-23

PRO-BOOST-LC

Affidea Nu-med Center of Oncological DIagnostics and Therapy

Phase 2/3 Recruiting
1,200 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07219303 2025-10-29

DE-CART

Fox Chase Cancer Center

Phase NA Recruiting
80 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06665932 2024-11-12

Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins

University Hospital Ostrava

Phase NA Recruiting
100 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡